Hunter Syndrome Treatment Market Size, Share, Analysis, Trends, Growth Report, 2030

Hunter Syndrome Treatment Market

Hunter Syndrome Treatment Market by Treatment (Hematopoietic Stem Cell Transplant (HSCT), Enzyme Replacement Therapy (ERT), and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Category: Healthcare Report Format : PDF Pages: 126 Report Code: ZMR-5333 Published Date: Mar-2020 Status : Published
Market Size in 2019 Market Forecast in 2026 CAGR (in %) Base Year
USD 927.9 Million USD 1,601.6 Million 8.2% 2019

Hunter Syndrome Treatment Market

Hunter Syndrome Treatment Industry Prospective:

The global hunter syndrome treatment market size was worth around $927.9 Million in 2019 and is predicted to grow to around $1,601.6 Million by 2026 with a compound annual growth rate (CAGR) of roughly 8.2% between 2019 and 2026.

The report analyzes the global hunter syndrome treatment market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the global hunter-syndrome treatment industry.

The report covers forecasts and analyses for the Hunter syndrome treatment market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the Hunter syndrome treatment market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the hunter syndrome treatment market on a global as well as regional level.

In order to give the users of this report a comprehensive view of the hunter syndrome treatment market we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Hunter Syndrome Treatment Market Request Free Sample

Hunter Syndrome Treatment Market: Overview

The report provides a company market share analysis in order to give a broader overview of the key players in the hunter syndrome treatment market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new indication launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the hunter syndrome treatment market on a global and regional basis.

The study provides a crucial view of the Hunter syndrome treatment by segmenting the market based on treatment and region. All the segments of the Hunter syndrome treatment market have been analyzed based on present and future trends and the market is estimated from 2016 to 2026.

Hunter Syndrome Treatment Market: Growth Factors

The global demand for the Hunter syndrome treatment market is driven by the expected approval of new therapies, growing research and development activities, and extended life expectancy. However, lack of awareness and high cost may act as restraining factors for the market growth in the coming years. Increasing collaboration and technological advancements are projected to bring new growth avenues for market players during the forecast timeframe.

Hunter Syndrome Treatment Market: Segmentation

The Hunter syndrome treatment market has been divided into treatment and region. Based on treatment, the global Hunter syndrome treatment market is segmented into Hematopoietic Stem Cell Transplant (HSCT), Enzyme Replacement Therapy (ERT), and others. The market was dominated by the Enzyme Replacement Therapy (ERT) segment in 2019 and is projected to retain its dominance over the forecast timeframe.

Hunter Syndrome Treatment Market: Report Scope

Report Attributes Report Details
Report Name Hunter Syndrome Treatment Market Research Report
Market Size in 2019 USD 927.9 Million
Market Forecast in 2026 USD 1,601.6 Million
Growth Rate CAGR of 8.2%
Number of Pages 255
Forecast Units Value (USD Billion), and Volume (Units)
Key Companies Covered GC Pharma, Takeda Pharmaceutical Company, RegenxBio Inc., JCR Pharmaceuticals Co Ltd., Sangamo Therapeutics, Inc., Inventiva S.A., ArmaGen Inc, Esteve, Bioasis Technologies Inc., Denali Therapeutics Inc among others.
Segments Covered By Treatment, And By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA)
Base Year 2019
Historical Year 2016 to 2019
Forecast Year 2020 - 2026
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Hunter Syndrome Treatment Market: Regional Analysis

North America held the largest revenue share of the global hunter syndrome treatment market in 2018. This large share is attributed to government funding, growing awareness, and the presence of key players in this region. Europe was second leading regional market in terms of revenue. Availability of developed infrastructure, increasing geriatric population, and growing awareness are major factors that support market growth in this region.

Asia Pacific region is projected to be a rapidly growing regional market for hunter syndrome treatment. Increasing chronic disease prevalence and geriatric population base, economic development, improvement of healthcare infrastructure, and growing awareness are major factors attributing to the swift growth in this region. Moderate growth is projected in the Latin America region over the forecast period. Middle East and Africa will witness sluggish growth in the coming years.

Hunter Syndrome Treatment Market: Competitive Players

Major players in the Hunter syndrome treatment market are 

  • GC Pharma
  • Takeda Pharmaceutical Company
  • RegenxBio Inc.
  • JCR Pharmaceuticals Co Ltd.
  • Sangamo Therapeutics. Inc.
  • Inventiva S.A.
  • ArmaGen Inc
  • Esteve
  • Bioasis Technologies Inc.
  • Denali Therapeutics Inc 
  • among others.

The report segment of global hunter syndrome treatment market as follows:

Global Hunter Syndrome Treatment Market: Treatment

  • Hematopoietic Stem Cell Transplant (HSCT)
  • Enzyme Replacement Therapy (ERT)
  • Others

Global Hunter Syndrome Treatment Market: By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Hunter syndrome, commonly known as mucopolysaccharidosis II (MPS II), is a rare genetic condition characterized by iduronate-2-sulfatase deficiency. This deficit causes glycosaminoglycans to accumulate in cells, creating a variety of progressive and debilitating symptoms.
 

The global demand for hunter syndrome treatment market is driven by expected approval of new therapies, growing research and development activities, and extended life expectancy.

According to the report, global demand for hunter syndrome treatment market was valued at approximately USD 927.9 million in 2019, and is expected to generate revenue of around USD 1,601.6 million by end of 2026, growing at a CAGR of around 8.2% between 2020 and 2026.

North America held largest revenue share of the global hunter syndrome treatment market in 2018. This large share is attributed to government funding, growing awareness and presence of key players in this region. 

Major players in hunter syndrome treatment market are GC Pharma, Takeda Pharmaceutical Company, RegenxBio Inc., JCR Pharmaceuticals Co Ltd., Sangamo Therapeutics, Inc., Inventiva S.A., ArmaGen Inc, Esteve, Bioasis Technologies Inc., and Denali Therapeutics Inc among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed